2022 annual financial data
Mereo BioPharma Group 2022 Operating margin
Direct answer
Operating margin was -3,561.21%.
Operating income was -53,667,430 GBP and net income was -42,121,955 GBP.
Operating cash flow was -48,821,000 GBP.
Get free Mereo BioPharma Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,507,000 GBP
- Operating income
- -53,667,430 GBP
- Net income
- -42,121,955 GBP
- Operating cash flow
- -48,821,000 GBP